Warburg effect and its role in tumourigenesis

Show simple item record

dc.contributor.author Lebelo, M.T. (Maphuti)
dc.contributor.author Joubert, Anna Margaretha
dc.contributor.author Visagie, M.H. (Michelle Helen)
dc.date.accessioned 2019-09-27T07:38:49Z
dc.date.issued 2019-10
dc.description.abstract Glucose is a crucial molecule in energy production and produces different end products in non-tumourigenic- and tumourigenic tissue metabolism. Tumourigenic cells oxidise glucose by fermentation and generate lactate and adenosine triphosphate even in the presence of oxygen (Warburg effect). The Na+/H+-antiporter is upregulated in tumourigenic cells resulting in release of lactate- and H+ ions into the extracellular space. Accumulation of lactate- and proton ions in the extracellular space results in an acidic environment that promotes invasion and metastasis. Otto Warburg reported that tumourigenic cells have defective mitochondria that produce less energy. However, decades later it became evident that these mitochondria have adapted with alterations in mitochondrial content, structure, function and activity. Mitochondrial biogenesis and mitophagy regulate the formation of new mitochondria and degradation of defective mitochondria in order to combat accumulation of mutagenic mitochondrial deoxyribonucleic acid. Tumourigenic cells also produce increase reactive oxygen species (ROS) resulting from upregulated glycolysis leading to pathogenesis including cancer. Moderate ROS levels exert proliferative- and prosurvival signaling, while high ROS quantities induce cell death. Understanding the crosstalk between aberrant metabolism, redox regulation, mitochondrial adaptions and pH regulation provides scientific- and medical communities with new opportunities to explore cancer therapies. en_ZA
dc.description.department Physiology en_ZA
dc.description.embargo 2020-08-31
dc.description.librarian hj2019 en_ZA
dc.description.sponsorship Funds were provided by Prof. AM Joubert who acquired grants from the National Research Foundation (Grant Nos. N00591, N00375, N00903, N01716), the Cancer Association of South Africa (Grant Nos. AOV741, AOW228), the Struwig Germeshuysen Trust, the School of Medicine Research Committee of the University of Pretoria and Medical Research Council of South Africa. Additional funding was provided by Dr. MH Visagie whom received grants from the National Research Foundation, the School of Medicine Research Committee of the University of Pretoria and Struwig Germeshysen Trust. en_ZA
dc.description.uri http://link.springer.com/journal/12272 en_ZA
dc.identifier.citation Lebelo, M.T., Joubert, A.M. & Visagie, M.H. Warburg effect and its role in tumourigenesis. Archives of Pharmacal Research (2019) 42: 833-847. https://doi.org/10.1007/s12272-019-01185-2. en_ZA
dc.identifier.issn 0253-6269 (print)
dc.identifier.issn 1976-3786 (online)
dc.identifier.other 10.1007/s12272-019-01185-2
dc.identifier.uri http://hdl.handle.net/2263/71464
dc.language.iso en en_ZA
dc.publisher Springer en_ZA
dc.rights © The Pharmaceutical Society of Korea 2019. The original publication is available at : http://link.springer.com/journal/12272. en_ZA
dc.subject Cancer en_ZA
dc.subject Acidity en_ZA
dc.subject Mitochondria en_ZA
dc.subject Mitophagy en_ZA
dc.subject Biogenesis en_ZA
dc.subject Reactive oxygen species (ROS) en_ZA
dc.subject Warburg effect en_ZA
dc.subject Tumourigenesis en_ZA
dc.title Warburg effect and its role in tumourigenesis en_ZA
dc.type Postprint Article en_ZA


Files in this item

This item appears in the following Collection(s)

Show simple item record